NasdaqGS:PGENBiotechs
Precigen (PGEN) Quarterly Loss Swings Challenge Bullish Growth Narrative After FY 2025 Results
Precigen (PGEN) has just closed out FY 2025 with fourth quarter revenue of US$4.6 million, a basic EPS loss of US$0.07, and net income loss of US$23.5 million. Over the past year, the company has seen revenue move from US$1.2 million in Q4 2024 to US$4.6 million in Q4 2025. Trailing twelve month basic EPS sits at a loss of US$1.37 and net income loss over the same period totals US$429.6 million, which keeps the spotlight firmly on how quickly margins can improve from here.
See our full...